128 related articles for article (PubMed ID: 34851180)
1. Bone metastases with post-treatment intralesional fatty content of the spine: imaging features from T1-weighted imaging with CT finding correlations.
Park S; Huh JD
Acta Radiol; 2023 Jan; 64(1):153-163. PubMed ID: 34851180
[TBL] [Abstract][Full Text] [Related]
2. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
3. MR Diagnosis of Bone Metastases at 1.5 T and 3 T: Can STIR Imaging Be Omitted?
Ohlmann-Knafo S; Tarnoki AD; Tarnoki DL; Pickuth D
Rofo; 2015 Oct; 187(10):924-32. PubMed ID: 26085176
[TBL] [Abstract][Full Text] [Related]
4. Clinical and experimental imaging of breast cancer metastases in the spine.
Petrén-Mallmin M
Acta Radiol Suppl; 1994; 391():1-23. PubMed ID: 8172006
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of bone metastases from benign red marrow depositions of the spine: the role of fat-suppressed T2-weighted imaging compared to fat fraction map.
Park S; Do Huh J
Eur Radiol; 2022 Oct; 32(10):6730-6738. PubMed ID: 35798881
[TBL] [Abstract][Full Text] [Related]
7. Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation.
Collins MS; Koyama T; Swee RG; Inwards CY
Skeletal Radiol; 2003 Dec; 32(12):687-94. PubMed ID: 14530882
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of skeletal metastases from medulloblastoma.
Algra PR; Postma T; Van Groeningen CJ; Van der Valk P; Bloem JL; Valk J
Skeletal Radiol; 1992; 21(7):425-30. PubMed ID: 1439892
[TBL] [Abstract][Full Text] [Related]
9. Which MRI sequence of the spine best reveals bone-marrow metastases of neuroblastoma?
Meyer JS; Siegel MJ; Farooqui SO; Jaramillo D; Fletcher BD; Hoffer FA
Pediatr Radiol; 2005 Aug; 35(8):778-85. PubMed ID: 15883828
[TBL] [Abstract][Full Text] [Related]
10. Synthetic CT for the planning of MR-HIFU treatment of bone metastases in pelvic and femoral bones: a feasibility study.
Lena B; Florkow MC; Ferrer CJ; van Stralen M; Seevinck PR; Vonken EPA; Boomsma MF; Slotman DJ; Viergever MA; Moonen CTW; Bos C; Bartels LW
Eur Radiol; 2022 Jul; 32(7):4537-4546. PubMed ID: 35190891
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing imaging features between spinal hyperplastic hematopoietic bone marrow and bone metastasis.
Shigematsu Y; Hirai T; Kawanaka K; Shiraishi S; Yoshida M; Kitajima M; Uetani H; Azuma M; Iryo Y; Yamashita Y
AJNR Am J Neuroradiol; 2014 Oct; 35(10):2013-20. PubMed ID: 24948497
[TBL] [Abstract][Full Text] [Related]
12. Comparison of MRI, CT and bone scintigraphy in metastases of experimental neoplasm.
Watanabe H; Sato T; Hisinuma T; Ogata Y
Tohoku J Exp Med; 1991 Mar; 163(3):229-31. PubMed ID: 2063405
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of dual-energy CT for the detection of traumatic bone marrow lesions in the ankle: comparison with MR imaging.
Guggenberger R; Gnannt R; Hodler J; Krauss B; Wanner GA; Csuka E; Payne B; Frauenfelder T; Andreisek G; Alkadhi H
Radiology; 2012 Jul; 264(1):164-73. PubMed ID: 22570505
[TBL] [Abstract][Full Text] [Related]
14. Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease.
Pasoglou V; Michoux N; Peeters F; Larbi A; Tombal B; Selleslagh T; Omoumi P; Vande Berg BC; Lecouvet FE
Radiology; 2015 Apr; 275(1):155-66. PubMed ID: 25513855
[TBL] [Abstract][Full Text] [Related]
15. Role of whole-body diffusion-weighted MRI in detecting bone metastasis.
Del Vescovo R; Frauenfelder G; Giurazza F; Piccolo CL; Cazzato RL; Grasso RF; Schena E; Zobel BB
Radiol Med; 2014 Oct; 119(10):758-66. PubMed ID: 24638912
[TBL] [Abstract][Full Text] [Related]
16. Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWI.
Eiber M; Holzapfel K; Ganter C; Epple K; Metz S; Geinitz H; Kübler H; Gaa J; Rummeny EJ; Beer AJ
J Magn Reson Imaging; 2011 May; 33(5):1160-70. PubMed ID: 21509875
[TBL] [Abstract][Full Text] [Related]
17. High signal intensity of intervertebral calcified disks on T1-weighted MR images resulting from fat content.
Malghem J; Lecouvet FE; François R; Vande Berg BC; Duprez T; Cosnard G; Maldague BE
Skeletal Radiol; 2005 Feb; 34(2):80-6. PubMed ID: 15480646
[TBL] [Abstract][Full Text] [Related]
18. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
19. MRI of bone tumors: Fast STIR imaging as a substitute for T1-weighted contrast-enhanced fat-suppressed spin-echo imaging.
Tokuda O; Hayashi N; Matsunaga N
J Magn Reson Imaging; 2004 Apr; 19(4):475-81. PubMed ID: 15065172
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.
Samarin A; Hüllner M; Queiroz MA; Stolzmann P; Burger IA; von Schulthess G; Veit-Haibach P
Nucl Med Commun; 2015 Dec; 36(12):1165-73. PubMed ID: 26397999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
